Form 8-K - Current report:
SEC Accession No. 0000950170-23-033278
Filing Date
2023-07-18
Accepted
2023-07-18 11:31:39
Documents
14
Period of Report
2023-07-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nept-20230717.htm   iXBRL 8-K 55765
2 EX-99.1 nept-ex99_1.htm EX-99.1 445476
3 GRAPHIC img153526410_0.jpg GRAPHIC 65953
  Complete submission text file 0000950170-23-033278.txt   735841

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nept-20230717_pre.xml EX-101.PRE 10304
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nept-20230717_lab.xml EX-101.LAB 14028
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nept-20230717.xsd EX-101.SCH 2490
8 EXTRACTED XBRL INSTANCE DOCUMENT nept-20230717_htm.xml XML 4939
Mailing Address 545 PROMENADE DU CENTROPOLIS SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS SUITE 100 LAVAL A8 H7T 0A3 (450) 687-2262
Neptune Wellness Solutions Inc. (Filer) CIK: 0001401395 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33526 | Film No.: 231093410
SIC: 2834 Pharmaceutical Preparations